TrialNature medicine2022

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial.

Felice Rivellese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.